ConductScience.org, home

Trial · NCT00915343

Participant flow27

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Part A - First Intervention PeriodSTARTEDHydrocortisone MR OD Then Hydrocortisone TID - Part A32
Part A - First Intervention PeriodSTARTEDHydrocortisone TID Then Hydrocortisone MR OD - Part A32
Part A - First Intervention PeriodSTARTEDHydrocortisone MR Tablet OD - Part B (All 6 Months)0
Part A - First Intervention PeriodCOMPLETEDHydrocortisone MR OD Then Hydrocortisone TID - Part A32
Part A - First Intervention PeriodCOMPLETEDHydrocortisone TID Then Hydrocortisone MR OD - Part A32
Part A - First Intervention PeriodCOMPLETEDHydrocortisone MR Tablet OD - Part B (All 6 Months)0
Part A - First Intervention PeriodNOT COMPLETEDHydrocortisone MR OD Then Hydrocortisone TID - Part A0
Part A - First Intervention PeriodNOT COMPLETEDHydrocortisone TID Then Hydrocortisone MR OD - Part A0
Part A - First Intervention PeriodNOT COMPLETEDHydrocortisone MR Tablet OD - Part B (All 6 Months)0
Part A - Second Intervention PeriodSTARTEDHydrocortisone MR OD Then Hydrocortisone TID - Part A32
Part A - Second Intervention PeriodSTARTEDHydrocortisone TID Then Hydrocortisone MR OD - Part A32
Part A - Second Intervention PeriodSTARTEDHydrocortisone MR Tablet OD - Part B (All 6 Months)0
Part A - Second Intervention PeriodCOMPLETEDHydrocortisone MR OD Then Hydrocortisone TID - Part A32
Part A - Second Intervention PeriodCOMPLETEDHydrocortisone TID Then Hydrocortisone MR OD - Part A32
Part A - Second Intervention PeriodCOMPLETEDHydrocortisone MR Tablet OD - Part B (All 6 Months)0
Part A - Second Intervention PeriodNOT COMPLETEDHydrocortisone MR OD Then Hydrocortisone TID - Part A0
Part A - Second Intervention PeriodNOT COMPLETEDHydrocortisone TID Then Hydrocortisone MR OD - Part A0
Part A - Second Intervention PeriodNOT COMPLETEDHydrocortisone MR Tablet OD - Part B (All 6 Months)0
Part B - Open Label PeriodSTARTEDHydrocortisone MR OD Then Hydrocortisone TID - Part A0
Part B - Open Label PeriodSTARTEDHydrocortisone TID Then Hydrocortisone MR OD - Part A0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00915343/flow